CONSIDERATIONS TO KNOW ABOUT AZELAPRAG SMALL MOLECULE

The biotech sought to bear this system out in STRIDES, a mid-phase, randomized, double-blinded and placebo-managed demo that evaluated the efficacy and protection of azelaprag—with and devoid of Eli Lilly’s blockbuster incretin therapy tirzepatide—in in excess of two hundred individuals with obesity., CEO of BioAge. "Presented its oral availa